KNSA logo

Kiniksa Pharmaceuticals (KNSA) Current liabilities

annual current liabilities:

$100.62M+$36.95M(+58.05%)
December 31, 2024

Summary

  • As of today (June 1, 2025), KNSA annual total current liabilities is $100.62 million, with the most recent change of +$36.95 million (+58.05%) on December 31, 2024.
  • During the last 3 years, KNSA annual current liabilities has risen by +$55.80 million (+124.48%).
  • KNSA annual current liabilities is now at all-time high.

Performance

KNSA Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAbalance sheet metrics

quarterly current liabilities:

$97.27M-$3.35M(-3.33%)
March 31, 2025

Summary

  • As of today (June 1, 2025), KNSA quarterly total current liabilities is $97.27 million, with the most recent change of -$3.35 million (-3.33%) on March 31, 2025.
  • Over the past year, KNSA quarterly current liabilities has increased by +$33.05 million (+51.48%).
  • KNSA quarterly current liabilities is now -3.33% below its all-time high of $100.62 million, reached on December 31, 2024.

Performance

KNSA quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

KNSA Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+58.0%+51.5%
3 y3 years+124.5%+93.2%
5 y5 years+261.6%+402.9%

KNSA Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+124.5%-3.3%+165.8%
5 y5-yearat high+261.6%-3.3%+402.9%
alltimeall timeat high+4271.0%-3.3%+458.0%

KNSA Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$97.27M(-3.3%)
Dec 2024
$100.62M(+58.0%)
$100.62M(+4.9%)
Sep 2024
-
$95.95M(+13.8%)
Jun 2024
-
$84.29M(+31.3%)
Mar 2024
-
$64.21M(+0.9%)
Dec 2023
$63.67M(+35.3%)
$63.67M(+19.1%)
Sep 2023
-
$53.47M(+12.6%)
Jun 2023
-
$47.47M(+29.8%)
Mar 2023
-
$36.59M(-22.3%)
Dec 2022
$47.07M(+5.0%)
$47.07M(-16.7%)
Sep 2022
-
$56.49M(+29.7%)
Jun 2022
-
$43.54M(-13.5%)
Mar 2022
-
$50.35M(+12.3%)
Dec 2021
$44.82M
$44.82M(+30.2%)
Sep 2021
-
$34.43M(-11.2%)
DateAnnualQuarterly
Jun 2021
-
$38.78M(+9.4%)
Mar 2021
-
$35.45M(+11.3%)
Dec 2020
$31.85M(+14.4%)
$31.85M(+27.9%)
Sep 2020
-
$24.89M(+21.1%)
Jun 2020
-
$20.55M(+6.3%)
Mar 2020
-
$19.34M(-30.5%)
Dec 2019
$27.83M(-34.6%)
$27.83M(+1.0%)
Sep 2019
-
$27.56M(-8.7%)
Jun 2019
-
$30.18M(-18.2%)
Mar 2019
-
$36.89M(-13.3%)
Dec 2018
$42.55M(+144.1%)
$42.55M(+51.9%)
Sep 2018
-
$28.02M(+21.1%)
Jun 2018
-
$23.14M(+20.1%)
Mar 2018
-
$19.27M(+10.5%)
Dec 2017
$17.43M(+657.2%)
$17.43M
Dec 2016
$2.30M
-

FAQ

  • What is Kiniksa Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual current liabilities year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly current liabilities year-on-year change?

What is Kiniksa Pharmaceuticals annual total current liabilities?

The current annual current liabilities of KNSA is $100.62M

What is the all time high annual current liabilities for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual total current liabilities is $100.62M

What is Kiniksa Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, KNSA annual total current liabilities has changed by +$36.95M (+58.05%)

What is Kiniksa Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of KNSA is $97.27M

What is the all time high quarterly current liabilities for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly total current liabilities is $100.62M

What is Kiniksa Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, KNSA quarterly total current liabilities has changed by +$33.05M (+51.48%)
On this page